Questions discussed in this category
If so, do you use it for all patients or only cisplatin doses >= 70 mg/m2? What dose of mannitol do you use?
What were your “top 3” presentations/studies coming out of the meeting this year and how will it impact your own clinical practice...
If you do not use prophylaxis, what skin care strategy do you employ?
Is it reasonable to dose de-escalate since survival will likely depend on the metastatic lung cancer?
What factors may favor RET inhibition versus observation?
Based on the results of the phase 2GORTEC study reference; Sun et al., PMID 32758455.
40 yo adult patient with a~6cm mass with concern for skull base bony involvement (group III and stage III, no nodal involvement )
Resected small bilateral tonsil SCC & base of tongue SCC.
The patient received 6 cycles of BEP 30 years ago for testicular cancer, and suffers fr...
Has your practice changed based on the randomized, phase 3 study showing prophylactic gabapentin is not effective?
Please share your thoughts and exp...
How do HPV-positive patients respond to ICI compared to HPV-negative in your experience?
What clinical criteria would make you prefer TORS as the initial treatment approach?
Patient received full dose concurrent cis + RT previously.
How do you stage? Like nasopharynx or p16+ oropharynx?
Do you treat it like npx ca with chemo xrt + adj chemo or like opx p16+ with definitive chemo ...
Has anyone tried this approach with success?
Lymph node is 4.5cm with no reported ECE. Does the size of the LN or presence or absence of ECE affect your decision?
Would you prioritize the head and neck cancer or treat the lung cancer first with SBRT to take care of it first? How about if there is mediastinal inv...
Would you elect for concurrent chemoRT or RT alone?
Or would you recommend upfront resection as long as borderline resectable?
What doses and constraints do you use?
Is there any role of radiation therapy for these patient for symptomatic relief?
Would you consider induction: TPF vs cis/gem or would you proceed with chemoradiation with cis/RT and consider adjuvant cis/5FU?
If so, how do you sequence it? Would you consider before adjuvant radiation vs concurrent with adjuvant (chemo)radiation vs after adjuvant radiation? ...
In the post-op setting, would you delay 1 week even if it took them out of the 6 weeks post-op window? Meaning the loading dose of erbitux was given d...
In primary surgical resection, ENE on surgical path would be indication to add adjuvant chemoradiation. After progression through definitive chemoradi...
If advanced stage do you follow same guidelines as Scc? Do you use same Cth regimen? Role of total laryngectomy ?
Would gross ENE or R1 resection trigger you to consider adding chemo? If so, do you use weekly cisplatin or cisplatin/etoposide?
In addition to TSH suppression, would you opt for RAI, targeted treatment based off NGS, or lenvatinib?
Are you employing more or less primary chemoRT v. surgery for some cancers? Are you dose de-escalating? What are issues radiation oncologists should b...
Would you consider it for a patient with good PS but with limited metastatic disease? What dose fractionation would you prefer?
How do you decide on other chemo regimen? (Dosing, frequency, carboplatin based, non-platinum based etc.)
Would you use Cetuximab?
Altered fractiona...
Is there data to support every 3 week dosage v. weekly?
Does the availability of first line checkpoint inhibitor therapy affect your treatment decision?
Do different modalities of imaging (PET vs MRI vs CT) help you to distinguish one etiology versus the others? What about other clinical characteristic...
Aside from smoking cessation, what interventions have you found useful to manage patients with chronic symptomatic laryngeal edema? Steroids seem to b...
Such as in patients who are elderly or have borderline performance status
How would you approach a patient who is receiving chemoRT but has confirmed COVID-19 with minor symptoms, as breaking treatment for 2 weeks quarantine...
Is there data for weekly versus every 3 week cisplatin in this setting?
For example, for a patient that has been through multiple disfiguring surgeries and radiation and wants to delay time to next resection.
Do you start with TKIs or platinums?
Specifically with reference to rural settings where the logistics of early in the week delivery may be more challenging.
-The data on induction for adult H&N ca has been mixed (excluded NPX) but recent data suggest a benefit for adult NPX.
-Given that this is standa...
Patient initially was started on cetuximab due to renal insufficiency of unclear chronicity (uncontrolled hypertension) that significantly improved du...
Although platinum/5-FU was used in KEYNOTE-048, can an alternative like carbo/paclitaxel be given since it may be better tolerated?
Given not surgical candidate and within 1 year of chemoRT (recurrence within RT field), would you repeat chemoRT, RT alone, or systemic therapy alone?...
NCCN suggests either concurrent chemoRT or induction chemotherapy in these patients.
Does your approach differ by EBV status?
Would you recommend surgery, definitive chemoRT, or chemotherapy alone?
Aggressive histology with tall cell variant papillary thyroid carcinoma that's progressed 2 months after RAI and while on TSH suppression, without tra...
Some ENTs advocate for a neck dissection as a way to avoid chemotherapy if there is a high chance there is no ECE. This is without removing the primar...
Would you proceed with induction chemotherapy (eg TPF or cis/gem) to downstage or neoadjuvant chemoRT? Would your approach be different if there is or...
Have you seen RAI or lenvatinib be efficacious for locally advanced disease — allowing for better surgical outcomes? Do you utilize EBRT?
If neck dissection was done, do you offer adjuvant chemo and/or XRT?
Do you have a time threshold for re-challenge with platinum? Of note, Checkmate 141 defined platinum refractory as relapse within 6 months of pl...
For the first treatment day (during combined chemo/XRT courses), is it ok to give XRT first then send the patient for chemo or should the chemo be giv...
Do you ever start radiation +/- 24-48 hrs from C1D1 for chemotherapy due to logistical barriers?
Do you prefer chemotherapy to start at beginning of ...
Is concurrent chemotherapy necessary for these patients?
Does papillary histology influence your decisions regarding surgery, chemo, radiation dose or nodal coverage?
Routinely? Only with oropharyngeal cancer etc.? Given that low expression of EGFR subset did better, do you believe there is a true benefit in cetuxim...
Would you offer locoregional control alone, locoregional with adjuvant therapy, or active surveillance?
Which of the systemic options would you give concurrently with radiation therapy in the adjuvant setting? According to NCCN guidelines, high dose...
In the context of the new staging systems and possible differences of HPV mediated vs smoking mediated oropharynx SCC, would you ever not recommend co...
If you recommend or use induction chemotherapy, what is your preferred chemotherapy regimen?
If not, what is your thyroid hormone withdrawal protocol? If so, would you still treat a patient with possibly metastatic disease?
Do you typically use 5-FU/cisplatin/cetuximab, or do you prefer other options?
If so, when? Although anemia is associated with worse local control in HN cancer, I don't know of any data that shows that blood transfusions can help...
Do HPV and/or PD-L1 status influence your decision making?
If a patient had a recurrence that was pathologically proven despite negative idodine scans, what imaging scans would you follow up with for surveilla...
Our ENT surgeons often tell patients with evidence of matted nodes on imaging that their swallowing function will be much worse after 70Gy as compared...
Definitive chemoradiation vs. surgery followed by adjuvant radiation/chemoradiation?
Even though we do not have the best data on the use of induction chemotherapy, what are current practices?
Is your practice different between HPV+ an...
124041324413011120721268512432101891205312052107051186011759116755049111781068411291110941095210878107811059298889301770298379147949792279367688888258963860384308427676380308005779375425537744159468986210658165876718651666266437633361654352582657865796566556915283565555805477539151605315526850664850486635093258465315512913409679401639793737347025071997185515731442102212321093430411290
Papers discussed in this category
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013-03-01
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014-09-01
The Lancet. Oncology, 2013-03
Cancer, 2004-03-15
Mayo Clinic proceedings, 2012-03
Oral oncology, 2016-09
Cancer, 2002-06-01
The Lancet. Oncology, 2010-01
Oral oncology, 2014-05
Head & neck, 2015-03
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016-04-20
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003-01-01
Cancer, 2010-10-01
Head & neck, 2016-04
Cancer, 1990-11-01
Ann. Oncol., 2010 Apr 28
J Clin Oncol, 2017 Dec 8
Radiother Oncol, 2011-01-01
Acta Oncol, 2011-10-01
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003-01-15
N. Engl. J. Med., 2008-09-11
JAMA otolaryngology-- head & neck surgery, 2016-11-01
Pain practice : the official journal of World Institute of Pain, 2017-11
Med Phys, 2013-08-01
Int. J. Radiat. Oncol. Biol. Phys., 2009-01-01
N. Engl. J. Med., 2012-05-03
N. Engl. J. Med., 2012-05-03
Cancer journal (Sudbury, Mass.), 2017
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009-04-20
Cancer,
Head Neck, 2019 Feb 01
The New England journal of medicine, 2018-02-22
Lancet, 2018 Nov 15
International journal of radiation oncology, biology, physics, 1994-06-15
International journal of radiation oncology, biology, physics, 2010-12-01
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2010-06
Int J Radiat Oncol Biol Phys,
N. Engl. J. Med., 2019 May 31
The New England journal of medicine, 2015-02-12
Oral oncology, 2017-06
The New England journal of medicine, 2018-11-22
J. Clin. Oncol., 2019 Sep 25
J Pharm Sci,
J. Clin. Oncol.,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019-06-20
Int. J. Radiat. Oncol. Biol. Phys.,
Lancet, 2019 Nov 01
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014-12-01
The Lancet. Oncology, 2017-09
J Natl Compr Canc Netw,
Future Oncol, 2016 Aug 23
Radiother Oncol, 2009 May 14
The New England journal of medicine, 2006-02-09
Lancet (London, England), 2019-01-05
J. Natl. Cancer Inst.,
Lancet Oncol., 2017 May 09
Cancer discovery, 2015-07
J Immunother Cancer,
J Clin Oncol, 2021 Apr 26
Eur J Cancer, 2019 Feb 13
Laryngoscope, 2014 Jul
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2016-12
Head Neck,
The New England journal of medicine, 2007-10-25
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998-04
N Engl J Med,
Int. J. Radiat. Oncol. Biol. Phys., 2011 Jun 15
Cancer, 2004-12-01
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017-05-10
The Lancet. Oncology, 2016-07
N Engl J Med, 2016 Oct 08
Int J Radiat Oncol Biol Phys, 2021 Nov 20
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008-07-01
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010-06-01
Head & neck, 2014-05
Lancet Oncol, 2020 Aug 03
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010-03-10
Cancer chemotherapy and pharmacology, 2003-07
J Oncol Pharm Pract, 2009 Sep 16
Cancer Treat Rep,
Ann Pharmacother, 2012 Jan 31
Lancet, 2021 Jun 07
International journal of radiation oncology, biology, physics, 2014-03-01
N Engl J Med, 2020 Sep 18
BMC Cancer, 2021 May 27